Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Coronary Obstruction Detection by Molecular Personalized Gene Expression (COMPASS)

This study has been completed.
Sponsor:
Collaborators:
Cardiovascular Research Foundation, New York
Piedmont Heart Institute, Inc., Atlanta, GA
Information provided by (Responsible Party):
CardioDx
ClinicalTrials.gov Identifier:
NCT01117506
First received: May 3, 2010
Last updated: November 25, 2014
Last verified: November 2014